ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making it much cheaper for the estimated 30,000 Australians with ...

LTR Pharma (ASX:LTP) has joined forces with Strategic Drug Solutions to developed a nasal spray to treat oesophageal motility ...

Approval is based on results from the Phase III ASCEND trial, in which patients using the powder achieved freedom from pain ...

The FDA just approved a new nasal application for allergy medicine. Pennsylvania law allows for school nurses to train other ...

For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...

Montgomery County is attributing a dramatic decline in drug deaths to efforts to prevent them, including availability of a ...

Discover 10 causes of nasal breathing difficulties from deviated septum to spray addiction, plus effective solutions for ...